The CoMO Scientific Advisory Group (CSAG) is a reference group of medical experts and clinicians. 

The group advise CoMO’s Governing Council on meningitis issues and immunisation projects across CoMO’s three regions – Americas, Asia Pacific and Europe Africa.


Dr James StuartProfessor James Stuart, London School of Hygiene and Tropical Medicine 
(London, UK)

CSAG Chair and CSAG Europe Africa Regional Representative

After qualifying in medicine, James worked as a clinical doctor in the UK and rural South Africa before specialising in public health. An infectious disease epidemiologist, James has been involved in outbreak investigation and control at an international level, and has published many papers on risk factors for meningococcal disease and carriage.


Professor Marco Aurélio P. Sáfadi, Santa Casa de São Paulo School of Medical Sciences (Sao Paulo, Brazil)

CSAG Americas Regional Representative

Marco is the Head of Paediatrics and Associate Professor at Santa Casa de São Paulo School of Medical Sciences. An infectious diseases specialist, Marco is an active member of the Advisory Board on Immunization Practices in Brazil. His research is focused on the epidemiology and prevention of community-acquired infections.


Dr May Montellano, Mary Chiles Hospital (Manila, Philippines)

CSAG Asia Pacific Regional Representative

May is a known Pediatric Infectious Disease Specialist in the Philippines. She is one of the founding members of the Pediatric Infectious Disease Society of the Philippines and Philippine Foundation for Vaccination. During her time, the Immunization Partners in Asia Pacific was organized. Currently, she is the Dean of the College of Medicine of Manila Theological College and the Head of Clinical Research Unit of Mary Chiles General Hospital and Far Eastern University-Nicanor Reyes Medical Foundation. She had several publications in the field of Clinical Research with more than 20 years of experience in vaccine clinical trials.  


Dr Mark Alderson, Center for Vaccine Innovation and Access, PATH
(Seattle, USA)

CSAG America's Regional Representative 

Mark is Director of PATH’s pneumococcal, group B streptococcal and polyvalent meningococcal vaccine projects that seek to accelerate the development, licensure and availability of promising new vaccines for use in low-income settings. Mark is an immunologist with more than 30 years of experience in medical research, biotechnology, pharmaceuticals and vaccine development.